AcelRx Pharmaceuticals (NASDAQ: ACRX) reported Q1 EPS of ($0.22), $0.01 better than the analyst estimate of ($0.23).

For earnings history and earnings-related data on AcelRx Pharmaceuticals (ACRX) click here.